Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  2008-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.2008.01163.xPMID 18331573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Melanoma

  2021cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Cancer risk among parents and siblings of patients with schizophrenia

  2007influential reference
• Risk Factors for Bladder Cancer

  2007cited by this paper
• Medical complications of anorexia nervosa and bulimia nervosa

  2006cited by this paper
• The effect of lifestyle factors on gynaecological cancer.

  2006cited by this paper
• Apoptotic mechanisms and the synaptic pathology of schizophrenia.

  2006cited by this paper
• Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines.

  2006cited by this paper
• Identifying Barriers and Facilitating Factors to Improve Screening Mammography Rates in Women Diagnosed with Mental Illness and Substance Use Disorders

  2006cited by this paper
• Medical comorbidity in women and men with schizophrenia

  2006cited by this paper
• Prolactin and breast cancer risk.

  2006cited by this paper
• Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

  2006cited by this paper
• Cancer risk among users of neuroleptic medication: a population-based cohort study

  2006cited by this paper
• Adjustment of meta-analyses on the basis of quality scores should be abandoned.

  2006cited by this paper
• Physical health and schizophrenia

  2006cited by this paper
• Health behavior in psychiatric in‐patients compared with a German general population sample

  2006cited by this paper
• Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.

  2005cited by this paper
• Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

  2005cited by this paper
• Apoptotic mechanisms in the pathophysiology of schizophrenia.

  2005cited by this paper
• Schizophrenia and cancer: an epidemiological study.

  2005influential reference
• Detection of functional single-nucleotide polymorphisms that affect apoptosis.

  2005cited by this paper
• Reduced cancer incidence among patients with schizophrenia

  2005cited by this paper
• Cancer in schizophrenia: is the risk higher or lower?

  2005influential reference
• A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

  2005cited by this paper
• Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.

  2004cited by this paper
• Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women

  2004cited by this paper
• Risk for cancer in parents of patients with schizophrenia.

  2004cited by this paper
• EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Did Finland’s Tobacco Control Act of 1976 have an impact on ever smoking? An examination based on male and female cohort trends

  2004cited by this paper
• Schizophrenia and the risk for breast cancer.

  2003cited by this paper
• Medical comorbidity in schizophrenia

  2003cited by this paper
• Health behaviors and health status of older women with schizophrenia.

  2002cited by this paper
• Dopamine antagonists and the development of breast cancer.

  2002cited by this paper
• Incidence of cancer among persons with schizophrenia and their relatives.

  2001influential reference
• Preventable physical illness in people with mental illness

  2001influential reference
• Schizophrenia and cancer: is there a need to invoke a protective gene?

  2001cited by this paper
• On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions.

  2001cited by this paper
• Mental disorders and cause-specific mortality

  2001cited by this paper
• Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men

  2000influential reference
• Epidemiology of melanoma

  2000cited by this paper
• Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates

  2000cited by this paper
• Smoking and chronic obstructive pulmonary disease.

  2000cited by this paper
• Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?

  2000cited by this paper
• Smoking in first-episode patients with schizophrenia.

  1999cited by this paper
• Trends in smoking prevalence in Danish adults, 1964—1994

  1998cited by this paper
• Excess mortality of mental disorder

  1998cited by this paper
• Trends in smoking prevalence in Danish adults, 1964-1994 : The influence of gender, age, and education

  1998cited by this paper
• Meta-analysis Spurious precision? Meta-analysis of observational studies

  1998cited by this paper
• Medical comorbidity in schizophrenia.

  1996cited by this paper
• The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women

  1996cited by this paper
• Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary.

  1995cited by this paper
• Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies.

  1995influential reference
• Meta-analysis/Shmeta-analysis.

  1994cited by this paper
• At least one in seven cases of cancer is caused by smoking. Global estimates for 1985

  1994cited by this paper
• Mortality and Causes of Death in First Admitted Schizophrenic Patients

  1993cited by this paper
• A Needs Survey among Patients in Leros Asylum

  1992cited by this paper
• Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients

  1992cited by this paper
• Cancer Incidence of Schizophrenic Patients Results of Record Linkage Studies in Three Countries

  1992influential reference
• The occurence of cancer in first admitted schizophrenic patients

  1992influential reference
• Prolactin and breast cancer risk

  1990cited by this paper
• Mortality and causes of death in schizophrenic patients in Denmark

  1990cited by this paper
• The incidence of cancer in schizophrenic patients.

  1989influential reference
• Diagnosis of cancer and autopsy rate in schizophrenic patients

  1987cited by this paper
• Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients

  1987cited by this paper
• [Diagnosis of cancer and autopsy rate in schizophrenic patients].

  1987cited by this paper
• Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients

  1987cited by this paper
• Incidence of cancer in patients diagnosed as schizophrenic in Denmark.

  1986cited by this paper
• Schizophrenia and physical disease: a preliminary analysis of the data from the Oxford Record Linkage Study

  1980cited by this paper

• Incidence and Outcomes of Head and Neck Cancer in Patients With Schizophrenia

  2025cites this paper
• Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models

  2025cites this paper
• Mental hospitalisation and its impact on mortality.

  2025cites this paper
• Clozapine and anti-cancer agents: a systematic literature review of case reports

  2025cites this paper
• Parental mental illness and the risk of offspring cancer in childhood: a pooled meta-analysis of English and Swedish national cohorts

  2025cites this paper
• Cancer in Severe Mental Illness Patients: A Retrospective Study

  2025cites this paper
• Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers

  2024cites this paper
• Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still

  2024cites this paper
• Causal effects between personality and psychiatric traits and lung cancer: a bidirectional two-sample Mendelian randomization and bibliometric study

  2024cites this paper
• Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis.

  2024cites this paper
• Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database

  2024cites this paper
• An exploration of the correlations between seven psychiatric disorders and the risks of breast cancer, breast benign tumors and breast inflammatory diseases: Mendelian randomization analyses

  2023cites this paper
• Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls

  2023cites this paper
• Breast cancer treatment disparities in patients with severe mental illness: A systematic review and meta‐analysis

  2023cites this paper
• Genetic trade‐offs between complex diseases and longevity

  2022cites this paper
• Doença Somática nas Pessoas com Doença Mental Grave

  2022cites this paper
• Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA

  2022cites this paper
• Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?

  2022cites this paper
• Cancer incidence and stage at diagnosis among people with recent‐onset psychotic disorders: A retrospective cohort study using health administrative data from Ontario, Canada

  2022influential citation
• Cancer incidence and stage at diagnosis among people with psychotic disorders: Systematic review and meta-analysis.

  2022cites this paper
• Case report: Schizophrenia and hypertrophic osteoarthropathy, a rare syndrome hiding a life‐threatening condition

  2022cites this paper
• Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer

  2021cites this paper
• Review of Mendelian Randomization Studies on Ovarian Cancer

  2021cites this paper
• Giant conjunctival melanoma in a paranoid schizophrenic man: A case report

  2021cites this paper
• Mental Health, Mitochondria, and the Battle of the Sexes

  2021cites this paper
• Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia

  2021cites this paper
• Excess mortality from cancer in people with mental illness—Out of sight and out of mind

  2021cites this paper
• Challenges in Treating Cancer Patients With Unstable Psychiatric Disorder

  2021cites this paper
• Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial

  2021cites this paper
• Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy.

  2021cites this paper
• Cancer risk in patients with bipolar disorder and unaffected siblings of such patients: A nationwide population‐based study

  2021cites this paper
• The Risk and The Course of Cancer Among People with Severe Mental Illness

  2021cites this paper
• Case report: Schizophrenia and hypertrophic osteoarthropathy, a rare syndrome hiding a life-threatening condition

  2021cites this paper
• Cancer care for people with mental disorders: A qualitative survey among cancer care and psychiatric care professionals in Japan

  2021cites this paper
• Association of the Maryland Medicaid Behavioral Health Home Program with Cancer Screening in People with Serious Mental Illness

  2020cites this paper
• Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report

  2020cites this paper
• Augmenting disease maps: a Bayesian meta-analysis approach

  2020cites this paper
• Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer

  2020cites this paper
• A shared genetic contribution to breast cancer and schizophrenia

  2020cites this paper
• Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unit.

  2020cites this paper
• Mental health among nonelderly adult cancer survivors: A national estimate

  2020cites this paper
• Two-sample Mendelian randomization study for schizophrenia and breast cancer

  2020cites this paper
• Mortality characteristics in Sudan in national psychiatric hospitals: 5-year review of hospital mortality

  2020cites this paper
• Association Between the Maryland Medicaid Behavioral Health Home Program and Cancer Screening in People With Serious Mental Illness.

  2020cites this paper
• Twelve-Month Prevalence of Psychiatric Morbidity in Cancer Patients in a Nigerian Oncology Centre

  2020cites this paper
• The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study

  2020cites this paper
• Cytotoxicity of SH-SY5Y Neuroblastoma Cells to the Antipsychotic Drugs, Chlorpromazine and Trifluoperazine, is via a Ca2+ -Mediated Apoptosis Process and Differentiation of These Cells with Retinoic Acid Makes Them More Resistant to Cell Death

  2020cites this paper
• Prevalence of Neoplasms among Former Adolescent Psychiatric Inpatients

  2019cites this paper
• The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness.

  2019cites this paper
• Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in Schizophrenia

  2019cites this paper
• Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide Danish register study.

  2019cites this paper
• Genome-phenome explorer (GePhEx): a tool for the visualization and interpretation of phenotypic relationships supported by genetic evidence

  2019cites this paper
• Lung cancer incidence in patients with schizophrenia: meta-analysis

  2019cites this paper
• The impact of severe mental illness on lung cancer mortality of patients with lung cancer in Finland in 1990-2013: a register-based cohort study.

  2019cites this paper
• Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia

  2019cites this paper
• Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis

  2019cites this paper
• Осложнения нейролептической гиперпролактинемии

  2018cites this paper
• Identification of shared genetic variants between schizophrenia and lung cancer

  2018cites this paper
• Incidence Rates and Risk of Hospital Registered Infections among Schizophrenia Patients before and after Onset of Illness: A Population-Based Nationwide Register Study

  2018cites this paper
• Construction et évaluation d’un parcours de prévention somatique destiné aux patients psychotiques et bipolaires suivis par un secteur de santé mentale

  2018cites this paper
• The Pivotal Roles of GSK 3 β in Glioma Biology

  2018cites this paper
• Inhibition of cancer stem cells promoted by Pimozide

  2018cites this paper
• What Can Stutterers Learn from the Neurodiversity Movement?

  2018cites this paper
• Glioma in Schizophrenia: Is the Risk Higher or Lower?

  2018cites this paper
• Impact of mental illness on care for somatic comorbidities in France: a nation-wide hospital-based observational study

  2018cites this paper
• Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011.

  2018cites this paper
• Deciphering the paradoxical incidence of cancer in schizophrenia

  2018cites this paper
• Complications of neuroleptic hyperprolactinaemia

  2018cites this paper
• Increased serum levels of spectrin degradation products in patients with schizophrenia

  2018cites this paper
• Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis

  2018cites this paper
• The Interplay among PINK1/PARKIN/Dj-1 Network during Mitochondrial Quality Control in Cancer Biology: Protein Interaction Analysis

  2018cites this paper
• Schizophrenie und somatische Komorbiditäten

  2017cites this paper
• Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

  2017cites this paper
• “Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases

  2017cites this paper
• Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies

  2017influential citation
• Impact of Genetic Variation on Human CaMKK2 Regulation by Ca2+-Calmodulin and Multisite Phosphorylation

  2017cites this paper
• Improving Breast Cancer Screening and Care for Women With Severe Mental Illness.

  2017cites this paper
• Schizophrenia and Cancer: Low Incidence, High Mortality

  2017cites this paper
• Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study.

  2017cites this paper
• The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies.

  2017cites this paper
• Cancer prevalence in Israeli men and women with schizophrenia.

  2017cites this paper
• Trifluoperazine Activates FOXO1-Related Signals to Inhibit Tumor Growth in Hepatocellular Carcinoma

  2017cites this paper
• Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset.

  2017cites this paper
• Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma

  2017cites this paper
• Female schizophrenia patients and risk of breast cancer: A population-based cohort study.

  2017cites this paper
• Docking Studies of a Series of Fluphenazine as Potential 1RE1(X-Ray Crystal Structure of Caspase-3) Inhibitors: A Rational Approach to Anticancer Drug Design

  2017cites this paper
• Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

  2017cites this paper
• Cardiovascular diseases among patients with schizophrenia.

  2016cites this paper
• Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

  2016cites this paper
• miRNAs and their role in the correlation between schizophrenia and cancer

  2016cites this paper
• DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond

  2016cites this paper
• Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

  2016cites this paper
• Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

  2016cites this paper
• Psychoses et cancers : puzzle épidémiologique ou brouillage de l’abord clinique des psychopathologies en oncologie ?

  2016cites this paper
• Cancer screening, prevention, and treatment in people with mental illness

  2016cites this paper
• Allele-specific expression of mutated in colorectal cancer (MCC) gene and alternative susceptibility to colorectal cancer in schizophrenia

  2016cites this paper
• Cancer co-occurrence patterns in Parkinson's disease and multiple sclerosis-Do they mirror immune system imbalances?

  2016cites this paper
• Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower?

  2016cites this paper
• Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

  2016cites this paper
• Dysfunction in the coagulation system and schizophrenia

  2016cites this paper